Schedule 13G ownership disclosure
AVANIR PHARMACEUTICALS
Security class unavailable · CUSIP: 05348P401
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,541,358
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086364-15-000849
- Form type
- SC 13G
- Filer
- AVANIR PHARMACEUTICALS, INC.
- CIK
- CIK 858803
- Filed
- Jan 26, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership